Drugs / SynRinse
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03154541 | Jun 2017 → May 2018 | chronic rhinosinusitis, cystic fibrosis | University of Washington | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Synrinse | “Drug: Synrinse” NCT03154541 ↗ |
| Modality | Other / unclassified | “modified natural glycopolymer” NCT03154541 ↗ |
| Route | Intranasal | “delivered via nasal irrigation” NCT03154541 ↗ |